Skip to main content

Table 8 Price ratios by medicine source and category for all medicine products and by therapeutic category, (median (interquartile range)), 2010–2014

From: How well does Malaysia achieve value for money in public sector purchasing of medicines? Evidence from medicines procurement prices from 2010 to 2014

WHO ATC level 1 category

Local generics

Imported generics

Originator

All products

1.45 (0.94–2.57)

2.14 (1.07–4.34)

4.04 (1.50–6.88)

A – Alimentary tract and metabolism

1.44 (1.18–2.57)

2.09 (1.24–4.71)

1.52 (0.97–4.39)

B – Blood and blood forming organs

1.95 (1.59–16.78)

4.89 (2.80–8.19)

3.20 (2.25–3.27)

C – Cardiovascular system

1.42 (0.81–2.09)

3.09 (1.00–4.37)

7.43 (4.60–14.59)

D – Dermatalogicals

1.00 (0.44–1.50)

1.46 (1.12–1.70)

1.08 (0.36–1.80)

G – Genito-urinary system and sex hormones

0.42 (0.39–0.52)

1.16 (0.56–2.84)

4.59 (3.12–6.43)

H - Systemic hormonal preparations, excluding sex hormones and insulins

1.70 (1.06–2.13)

0.82 (0.58–1.33)

0.52 (0.23–0.91)

J – Anti-infectives for systemic use

1.80 (1.24–4.33)

2.74 (1.60–5.00)

4.45 (1.92–7.79)

L – Antineoplastic agents and immunomodulating agents

1.28 (0.46–2.55)

1.73 (1.70–2.13)

M – Musculo-skeletal system

1.11 (0.45–1.88)

4.28 (2.72–6.77)

5.13 (1.42–8.74)

N – Nervous system

1.17 (0.66–2.69)

2.24 (1.57–6.21)

4.35 (1.03–5.19)

P – Antiparasitic products, insecticides and repellents

1.79 (1.28–2.00)

3.14

R – Respiratory system

2.13 (0.62–3.57)

1.75 (1.06–4.25)

S – Sensory organs

1.13 (0.82–1.32)

2.36 (1.42–3.46)

0.65 (0.22–5.57)